Diagnostics pre-clinical services program IDIQ - advanced bioscience lab
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N93023D00015
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 4 $1,654,751 obligated
Award facts
- Opportunity
-
- Diagnostics pre-clinical services program Pre-Solicitation · Posted Dec 21, 2021
- Combined order value
-
- $1,654,751 Current, with exercised options
- $2,056,569 Potential, with all options
- Last date to order 48% complete
- IDV ceiling 7% used
- $24,000,000.00
- Maximum order
- $24,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 12 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases awarded an indefinite-delivery contract to Advanced Bioscience Laboratories, Inc. with a ceiling of $24 million and a single-award designation on June 20, 2023.
The Diagnostics Pre-Clinical Services Program IDIQ supports in vitro diagnostic product development for the detection, identification, and characterization of human infectious agents. The contract spans preclinical development services including cGMP manufacturing, analytical testing, quality assurance, reagent provision, and biological materials handling for vaccines, biologics, and diagnostic products targeting infectious diseases.
Performance occurs at Rockville, Maryland. The period of performance runs through June 19, 2030. Work falls under NAICS 541711 and PSC D399.
The originating pre-solicitation, posted December 21, 2021, anticipated multiple IDIQ awards beginning June 2023; the source confirms this award as a single-award vehicle rather than one of multiple concurrent awards. The solicitation sought capability statements from small businesses, though the source does not indicate Advanced Bioscience Laboratories, Inc. holds small business status.
Two delivery orders issued under this IDIQ, each valued at $3,500 on a firm-fixed-price basis and performed at Rockville, Maryland, with periods of performance through June 19, 2030.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93023D00015?
75N93023D00015 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 20, 2023.
How much is contract 75N93023D00015 worth?
Orders under 75N93023D00015 have obligated $1,654,751. Their combined potential value, with all options, is $2,056,569. 75N93023D00015's own ceiling is $24,000,000. A single order can be worth up to $24,000,000.
How many orders have been placed under contract 75N93023D00015?
4 orders have been placed under 75N93023D00015, the latest on September 7, 2026.
Who can order from contract 75N93023D00015?
75N93023D00015 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N93023D00015 competed?
The extent of competition for 75N93023D00015 was full and open competition. The government received 12 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV